Skip to main content
Erschienen in: Cardiovascular Toxicology 2/2012

01.06.2012

What are the Values of Using QTc and N-Terminal Fragment of B-Type Natriuretic Peptide as Markers for Early Detection of Acute Antipsychotic Drugs-Induced Cardiotoxicity?

verfasst von: Hossein Sanaei-Zadeh

Erschienen in: Cardiovascular Toxicology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
1.
Zurück zum Zitat Khalaf, M. A., Abdelrahman, T. M., & Abbas, M. F. (2011). Values of using QTc and N-terminal fragment of B-type natriuretic peptide as markers for early detection of acute antipsychotic drugs-induced cardiotoxicity. Cardiovascular Toxicology, 11(1), 10–17.PubMedCrossRef Khalaf, M. A., Abdelrahman, T. M., & Abbas, M. F. (2011). Values of using QTc and N-terminal fragment of B-type natriuretic peptide as markers for early detection of acute antipsychotic drugs-induced cardiotoxicity. Cardiovascular Toxicology, 11(1), 10–17.PubMedCrossRef
2.
Zurück zum Zitat Chan, D., & Ng, L. L. (2010). Biomarkers in acute myocardial infarction. BMC Medicine, 8, 34.PubMedCrossRef Chan, D., & Ng, L. L. (2010). Biomarkers in acute myocardial infarction. BMC Medicine, 8, 34.PubMedCrossRef
3.
Zurück zum Zitat Thejus, J., & Francis, J. (2009). N-terminal pro-brain natriuretic peptide and atrial fibrillation. Indian Pacing and Electrophysiology Journal, 9(1), 1–4.PubMed Thejus, J., & Francis, J. (2009). N-terminal pro-brain natriuretic peptide and atrial fibrillation. Indian Pacing and Electrophysiology Journal, 9(1), 1–4.PubMed
4.
Zurück zum Zitat Rademaker, M. T., & Richards, A. M. (2005). Cardiac natriuretic peptides for cardiac health. Clinical Science (London), 108(1), 23–36.CrossRef Rademaker, M. T., & Richards, A. M. (2005). Cardiac natriuretic peptides for cardiac health. Clinical Science (London), 108(1), 23–36.CrossRef
5.
Zurück zum Zitat Richards, A. M., & Frampton, C. M. (2005). N-terminal-Pro-B–type natriuretic peptide: Universal marker of cardiovascular risk? Circulation, 112, 9–11.PubMedCrossRef Richards, A. M., & Frampton, C. M. (2005). N-terminal-Pro-B–type natriuretic peptide: Universal marker of cardiovascular risk? Circulation, 112, 9–11.PubMedCrossRef
6.
Zurück zum Zitat Kropp, S., Tountopoulou, A., Schneider, U., & Lichtinghagen, R. (2005). N-terminal fragment of B-type natriuretic peptide (NT-proBNP), a marker of cardiac safety during antipsychotic treatment. Annals of General Psychiatry, 4, 10.PubMedCrossRef Kropp, S., Tountopoulou, A., Schneider, U., & Lichtinghagen, R. (2005). N-terminal fragment of B-type natriuretic peptide (NT-proBNP), a marker of cardiac safety during antipsychotic treatment. Annals of General Psychiatry, 4, 10.PubMedCrossRef
7.
Zurück zum Zitat Chan, A., Isbister, G. K., Kirkpatrick, C. M., & Dufful, S. B. (2007). Drug-induced QT prolongation and torsades de pointes: Evaluation of a QT nomogram. The Quarterly Journal of Medicine, 100(10), 609–615.CrossRef Chan, A., Isbister, G. K., Kirkpatrick, C. M., & Dufful, S. B. (2007). Drug-induced QT prolongation and torsades de pointes: Evaluation of a QT nomogram. The Quarterly Journal of Medicine, 100(10), 609–615.CrossRef
Metadaten
Titel
What are the Values of Using QTc and N-Terminal Fragment of B-Type Natriuretic Peptide as Markers for Early Detection of Acute Antipsychotic Drugs-Induced Cardiotoxicity?
verfasst von
Hossein Sanaei-Zadeh
Publikationsdatum
01.06.2012
Verlag
Humana Press Inc
Erschienen in
Cardiovascular Toxicology / Ausgabe 2/2012
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-011-9151-x

Weitere Artikel der Ausgabe 2/2012

Cardiovascular Toxicology 2/2012 Zur Ausgabe